Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hedgehog signaling inhibitors claimed by Lilly for cancer therapy

June 7, 2010

Phase III RADIANT-3 trial of everolimus meets primary endpoint

June 4, 2010

FDA grants fast track status to AS-1413 for secondary AML

June 4, 2010

REDUCE and CombAT trial data presented on dutasteride in prostate cancer

June 4, 2010

Sunesis receives scientific advice from EMA on voreloxin program

June 3, 2010

Lorus files IND for phase I trial of anticancer agent LOR-253

June 3, 2010

Final data reported of halted phase III idronoxil trial in ovarian cancer

June 3, 2010

LLS and Onconova partner to develop ESTYBON in high-risk MDS

June 3, 2010

Belgian FAMHP clears phase III Reolysin trial in head and neck cancers

June 3, 2010

Bayer Schering Pharma claims new HIF-1 inhibitors

June 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...